Advertisement

Topics

First Potential Vaccine for Chikungunya Virus Flies Through Phase II

09:58 EST 6 Nov 2018 | Labiotech.eu

The mosquito-borne chikungunya virus may one day have a vaccine, as an Austrian biotech’s lead candidate gets positive results in Phase II. Themis Bioscience measured the blood levels of antibodies against the company’s vaccine in 263 healthy volunteers. Four weeks ...

The post First Potential Vaccine for Chikungunya Virus Flies Through Phase II appeared first on Labiotech.eu.

Original Article: First Potential Vaccine for Chikungunya Virus Flies Through Phase II

NEXT ARTICLE

More From BioPortfolio on "First Potential Vaccine for Chikungunya Virus Flies Through Phase II"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...